ZAMBON, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.540
EU - Europa 3.562
AS - Asia 1.355
SA - Sud America 16
AF - Africa 9
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.488
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.493
IT - Italia 1.067
GB - Regno Unito 737
DE - Germania 595
SE - Svezia 573
HK - Hong Kong 445
CN - Cina 351
SG - Singapore 335
UA - Ucraina 140
FR - Francia 128
BG - Bulgaria 74
FI - Finlandia 64
ID - Indonesia 61
TR - Turchia 42
CA - Canada 36
IE - Irlanda 34
BE - Belgio 30
IN - India 29
NL - Olanda 27
RU - Federazione Russa 24
MY - Malesia 21
KR - Corea 20
IR - Iran 14
CH - Svizzera 11
LT - Lituania 10
VN - Vietnam 10
MX - Messico 9
PL - Polonia 9
BR - Brasile 7
ES - Italia 7
CZ - Repubblica Ceca 5
DK - Danimarca 5
RO - Romania 5
CO - Colombia 4
DZ - Algeria 4
HU - Ungheria 4
JP - Giappone 4
PH - Filippine 4
PK - Pakistan 4
TH - Thailandia 4
AT - Austria 3
AU - Australia 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BZ - Belize 2
EU - Europa 2
GR - Grecia 2
LU - Lussemburgo 2
MA - Marocco 2
SI - Slovenia 2
AM - Armenia 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
SC - Seychelles 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 12.488
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.062
Fairfield 1.030
Woodbridge 629
Southend 576
Chandler 568
Ashburn 495
Houston 482
Ann Arbor 439
Hong Kong 433
Nyköping 384
Seattle 379
Modena 377
Cambridge 374
Frankfurt am Main 321
Wilmington 318
Singapore 286
Jacksonville 226
Dearborn 222
Beijing 100
San Diego 83
Princeton 75
Bremen 73
Sofia 73
Eugene 65
Helsinki 58
Jakarta 57
Bologna 55
Boardman 52
London 39
Izmir 30
Redwood City 30
Dublin 29
Brussels 28
Reggio Emilia 28
Parma 24
Shanghai 22
Bomporto 21
Falls Church 19
Milan 19
Munich 19
Norwalk 19
Voghera 17
Hefei 16
New York 16
Toronto 16
Amsterdam 15
Florence 13
Des Moines 12
Moscow 12
Seongnam 12
Turin 12
Carpi 11
Mira 11
Castel San Giovanni 10
Ottawa 10
Rome 10
Padova 9
Paris 9
Chiswick 8
Guangzhou 8
Kunming 8
Vignola 8
Weihai 8
Catania 7
Dong Ket 7
Formigine 7
Nanjing 7
Sarezzano 7
Zhengzhou 7
Alseno 6
Grafing 6
Hebei 6
Krakow 6
Lappeenranta 6
Napoli 6
Prescot 6
Sassuolo 6
Chicago 5
Duncan 5
Fort Worth 5
Indiana 5
Kilburn 5
Menlo Park 5
Naples 5
San Cesario sul Panaro 5
San Giovanni in Persiceto 5
San Jose 5
West Jordan 5
Budapest 4
Chengdu 4
Chions 4
Geneva 4
Harlow 4
Kongens Lyngby 4
Las Vegas 4
Los Angeles 4
Monticello Conte Otto 4
Nanchang 4
Nuremberg 4
Reggio Nell'emilia 4
Totale 10.063
Salva come PNG Salva come JPEG
Nome #
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships 457
Chiral polycyclic ketones via desymmetrization of dihaloolefins 276
1 - ( 5 - TERT - BUTYL - 2 - ARYL - PYRAZOL - 3 - YL ) . 3 - 12 - FLUORO - 4 - [ ( 3 - OXO - 4H - PYRIDO [ 2 . 3 - BJPYRAZIN - 8 - YL ) OXY | PHENYLJUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 267
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma 264
Potential of wickerhamomyces anomalus in glycerol valorization 258
Cytocompatibility of potential bioactive cerium-doped glasses based on 45S5 246
A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitors 230
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 218
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors 204
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring 203
BRAF as a therapeutic target: A patent review (2006-2012) 203
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 201
Tris-annelated benzenes selectively perfunctionalized on one side only: Hexachlorobenzotrinorbornadiene as a versatile scaffold for the construction of molecular domes 198
Mesoporous bioactive glasses doped with cerium: Investigation over enzymatic-like mimetic activities and bioactivity 195
Abstract 3704: Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations 194
Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents 191
A novel mechanism for the fluxional behaviour of [Pd(η2-tetramethylethylenetetracarboxylate)(2-methylthiomethylpyridine)] 190
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling 187
Synthesis of the syn and anti isomer of 1,4,5,8,9,12-hexahydro-2,3,6,7,10,11-hexamethylidene-1,4 : 5,8 : 9,12-trimethanotriphenylene and Diels-Alder reactivity of the syn isomer 186
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): Increasing cellular potency through optimization of a distal heteroaromatic group 184
Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors 184
Development and exploitation of CK2 inhibitors 183
The discovery of novel, highly potent inhibitors of BRAF 183
Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma 180
Cerium Containing Bioactive Glasses: A Review 180
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF 177
Novel Potent BRAF Inhibitors: Toward 1 nM Compounds through Optimization of the Central Phenyl Ring 176
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds 172
Study on the toxicity of phenolic and phenoxy herbicides using the submitochondrial particle assay 172
Internal motions in a fulleropyrrolidine tertiary amide with axial chirality 171
Synthesis and evaluation of new chiral diols based on the dicyclopentadiene skeleton 170
Efficient cyclotrimerization of bicyclic vic-bromostannylalkenes promoted by copper(I) thiophen-2-carboxylate 169
Surface acidity modifications induced by thermal treatments and acid leaching on microcrystalline H-BEA zeolite. A FTIR, XRD and MAS-NMR study 168
Efficient access to 5-substituted thiazoles by a novel metallotropic rearrangement 168
Assessment of chloroaniline toxicity by the submitochondrial particle assay 167
Substituted aniline interaction with submitochondrial particles and quantitative structure-activity relationships 166
Isolation and characterization of all eight bisadducts of fulleropyrrolidine derivatives 162
Boosting sunscreen stability: New hybrid materials from UV filters encapsulation 161
Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives 157
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors 157
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF) 157
Investigation on the antimicrobial properties of cerium-doped bioactive glasses 156
Thiophene based A-D-A small molecules with a dithienosilole core: synthesis, theoretical calculations and optoelectronic properties 155
Gatekeeper mutations mediate resistance to BRAF-targeted therapies 155
Small molecule inhibitors of BRAF in clinical trials 154
Qualitative and quantitative discrimination of fake and true alkene rotation processes in pd(η2-olefin) complexes. A new bimolecular mechanism 153
"Hexacarboxytrindanes": Benzene rings with homotopic faces as scaffolds for the construction of D3 chiral architectures 152
Nucleoside 2’,3’-cyclic monophosphates in Aphanizomenon flos-aquae detected through nuclear magnetic resonance and mass spectrometry 151
Dual Kinase Targeting in Leukemia 145
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy 144
Novel oligothiophenes with reduced HOMO-LUMO band gap for Optoelectonics 142
β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics 142
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma 138
Nucleophilic reactions at the ring carbons of thiiranium and thiirenium ions. An experimental and theoretical comparison of the S(N)2 and S(N)2-Vin mechanisms 137
1-(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-2-FLUORO-4-(3-OXO-4H-PYRIDO2,3-BPYRAZIN-8-YL)OXYPHENYLUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 129
Non canonical Cyclic Nucleotides Monophosphates in Aphanizomenon flosaquae: nuclear magnetic resonance and mass spectrometry 125
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 123
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 119
Expedient Access to Type II Kinase Inhibitor Chemotypes by Microwave-Assisted Suzuki Coupling 119
Synthetic approach to novel NMP/ALK inhibitors 114
Toward the Scale-Up of a Bicyclic Homopiperazine via Schmidt Rearrangement and Photochemical Oxaziridine Rearrangement in Continuous-Flow 114
LYSYL OXIDASE INHIBITORS 112
Paradoxical activation of the MEK/ERK pathway promotes melanoma invasion and metastasis 107
Rational design of inhibitors of the anaplastic lymphoma kinase 104
Non-canonical Cyclic Nucleoside Monophosphates in Aphanizomenon flos-aquae: nuclear magnetic resonance and mass spectrometry 104
Ce-MBGs Loaded with Gentamicin: Characterization and In Vitro Evaluation 102
Loading with Biomolecules Modulates the Antioxidant Activity of Cerium-Doped Bioactive Glasses 102
endo-1-Phenylborneol as a novel, alternative chiral auxiliary for the aza-Diels-Alder reaction 98
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers 86
Preparation of 1-​(5-​tert-​butyl-​2-​aryl-​pyrazol-​3-​yl)​-​3-​[2-​fluoro-​4-​[(3-​oxo-​4H-​pyrido[2,​3-​b]​pyrazin-​8-​yl)​oxy]​phenyl]​urea derivatives as RAF inhibitors for treating cancer 85
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase 85
Erratum: Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase (ACS Omega (2022) 7:20 (17083-17097) DOI: 10.1021/acsomega.2c00507) 78
PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H PYRIDO2,3-B PYRAZIN-3-ONE DERIVATIVES 75
NON CANONICAL CYCLIC NUCLEOTIDES MONOPHOSPHATES IN APHANIZOMENON FLOS-AQUAE: NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY 71
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase 69
Dual loaded Ce-MBGs with bioactivity, antioxidant and antibacterial properties 59
Biostimulants derived from organic urban wastes and biomasses: An innovative approach 55
Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006)) 51
Corrections to pyridoimidazolones as novel potent inhibitors of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) (Journal of Medicinal Chemistry (2009) 52, (2255-2256) DOI: 10.1021/jm801509w) 44
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 37
Bifunctional mesoporous glasses for bone tissue engineering: Biological effects of doping with cerium and polyphenols in 2D and 3D in vitro models 36
Erratum: Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma (Journal of Investigative Dermatology (2013) 133 (274-276) DOI: 10.1038/jid.2012.268;0 36
Evaluation of the behaviour of hydrogels containing mesoporous glasses doped with cerium and loaded with polyphenols 28
Extraction, purification and in vitro assessment of the antioxidant and anti-inflammatory activity of policosanols from non-psychoactive Cannabis sativa L 26
Long-term durability of discarded cork-based composites obtained by geopolymerization 22
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 21
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 20
Novel ligands from direct benzylic functionalisation of tris(2-pyridylmethyl)amine 18
Totale 12.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.611 0 0 0 0 0 336 350 296 275 112 148 94
2020/20211.773 188 63 151 154 121 98 215 205 130 194 135 119
2021/20221.666 95 210 201 58 73 89 99 82 188 96 288 187
2022/20231.967 245 218 134 187 258 249 71 176 246 46 76 61
2023/20241.625 52 94 110 97 514 43 278 178 43 48 52 116
2024/20251.746 126 43 125 203 806 443 0 0 0 0 0 0
Totale 12.630